Volume 7 - Issue 1 - January 2010
Case Report and Brief Review
Bryan Cogar, MD and Mazan Abu-Fadel, MD, FACC
pg. E31 - E33
_______________________
Abstract
Arterial occlusion from the use of suture-mediated closure devices following a percutaneous procedure is a very rare but clinically significant complication for which surgical intervention is thought…
Clinical Review
Mallik Thatipelli, MD, RVT, FSVM, FACPh, FACC and Sanjay Misra, MD*
pg. E27 - E30
__________________________
Introduction and Epidemiology
Isolated atherosclerotic involvement of the common femoral artery (CFA) and its bifurcation are rare and reports consisting large patient series are unavailable. The CFA is u…
Clinical Review
Muhammad Raza, MD*, Bilal Ayub, MD§, Firas Alani, MD£, Mrinalini Meesala, MD*,
Daniel Gzesh, MD*, Sheldon Goldberg, MD*, Daniel J. McCormick, DO*
pg. E20 - E26
_________________________
Introduction
Each year about 780,000 people experience a new or recurrent stroke, accounting for 17% of cardiovascular deaths.1 Approximately 80% of strokes are caused by focal cerebral ischemia and the re…
Technology Overview
Aimee N. di Marco, MD*§, Celia V. Riga, MD*§, Mohamad Hamady, MD£,
Nicholas J. W. Cheshire, MD*§, Colin D. Bicknell, MD*§
pg. E15 - E19
_________________________
Introduction
Endovascular treatment of arterial disease has been a revolution for clinicians and patients alike, allowing treatment of aortic and peripheral pathologies percutaneously or through small inci…
Feature - Special Focus: Transcatheter Aortic Valve Implantation
Ulrich Gerckens, MD, George Latsios, MD, Eberhard Grube, MD
Transcatheter Aortic Valve Implantation: Clinical Experience with the Self-expanding Medtronic CoreValve Prosthesis Implantation through a Trans-subclavian Approach
pg. E10 - E14
____________________
Abstract
Calcified degenerative aortic valve…
Feature - Special Focus: Transcatheter Aortic Valve Implantation
Itsik Ben-Dor, MD, Ron Waksman, MD, Lowell F. Satler, MD, Augusto D. Pichard, MD
pg. E1 - E9
______________________
Abstract
The development of transcatheter aortic valve implantation may become the primary therapy for high-risk patients with severe symptomatic aortic stenosis. The Edwards Sapien valve (Edwards Lifesciences,…
Editor's Corner
Frank J. Criado
Editor-in-Chief
Vascular Surgery and Endovascular Intervention; Union Memorial Hospital/MedStar Health,
Baltimore, Maryland
frank.criado@medstar.net
pg. A1
______________________
At the dawn of a new decade, it is with pleasure and a sense of excitement that I write the first Corner editorial of 2010 to introduce a new format for Vascular Disease Management as it becomes an online-only public…
Commentary - Special Focus: Transcatheter Aortic Valve Implantation
Stefan C. Bertog, MD, Jakob Ledwoch, Nina Wunderlich, MD, Horst Sievert, MD
pg.E34 - E36
________________________
To evaluate the current and future role of percutaneous aortic valve replacement, we need to ask three main questions:
1. What is the natural history of the disease and where did we stand after the widesprea…
Back to Top